(Q38065010)

28 August 2017

1 reference

title

Understanding synergy (English)

1 reference

28 August 2017

Nori Geary

1

1 reference

28 August 2017

publication date

4 December 2012

1 reference

American Journal of Physiology - Endocrinology and Metabolism

28 August 2017

published in

1 reference

28 August 2017

volume

304

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

E237-53

1 reference

Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Insulin and leptin combine additively to reduce food intake and body weight in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The expected effect of a combination of agents: the general solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Systematic discovery of multicomponent therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Mathematical formulation of additivity for antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Sir Charles Sherrington's the integrative action of the nervous system: a centenary appreciation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Hormesis: the dose-response revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The quantitative analysis of drug-receptor interactions: a short history

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combined effects of oleoyl-estrone and a β3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Flexible interaction model for complex interactions of multiple anesthetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Systems biology and combination therapy in the quest for clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic analysis of interactions: an update on applications and utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The Hill equation and the origin of quantitative pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The Hill equation: a review of its capabilities in pharmacological modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic analysis for combinations of a full and partial agonist: curved isoboles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Leptin and the systems neuroscience of meal size control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Do general anesthetics add up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Sevoflurane remifentanil interaction: comparison of different response surface models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin, and bombesin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Generalized concentration addition: a method for examining mixtures containing partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Ten questions about systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Novel peptide-peptide cooperation may transform feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Regulation of blood pressure and salt homeostasis by endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Dose-additive inhibition of intake of ethanol by cholecystokinin and bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Pancreatic glucagon and cholecystokinin synergistically inhibit sham feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Drug interaction: focusing on response surface models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Synergistic drug combinations tend to improve therapeutically relevant selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Comments on "Isobolographic analysis for combinations of a full and partial agonist: curved isoboles".

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Analysis and comparison of sigmoidal curves: application to dose-response data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Response surface model for anesthetic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Gut peptides in the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Leptin action in the forebrain regulates the hindbrain response to satiety signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Erroneous analyses of interactions in neuroscience: a problem of significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Prediction and assessment of the effects of mixtures of four xenoestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Statistical modeling of the effects of drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Evaluation of experimental combined toxicity by use of dose-frequency curves: comparison with theoretical additivity as well as independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combination drugs--hype, harm, and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Central insulin enhances sensitivity to cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Amylin and insulin interact to reduce food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Response surface modeling of the interaction between propofol and sevoflurane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Gastric loads potentiate inhibition of food intake produced by a cholecystokinin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Hypothalamic apolipoprotein A-IV is regulated by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Cholecystokinin and bombesin act independently to decrease food intake in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Application and review of the separate ray model to investigate interaction effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Parallel dose-response curves in combination experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The SYNERGY trial: study design and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Interactions between drugs and occupied receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

An overview of drug combination analysis with isobolograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Hormones in synergy: regulation of the pituitary gonadotropin genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Mechanisms of amylin/leptin synergy in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Weighing benefits and risks--the FDA's review of prasugrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Fos expression in the brain induced by peripheral injection of CCK or leptin plus CCK in fasted lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Approaches to the study of drug interactions in behavioral pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

A formal model for analyzing drug combination effects and its application in TNF-alpha-induced NFkappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Good manners in good modeling: mathematical models and computer simulations of physiological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Functional classification of drugs by properties of their pairwise interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Multi-target therapeutics: when the whole is greater than the sum of the parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

Effects of Combined Oleoyl-Estrone and Rimonabant on Overweight Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00308.2012

10.1152/AJPENDO.00308.2012

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference